Cole G Bradley
- SEC CIK
- 0001337798
In the past year, 2 open-market sale filings worth $509.8K and no purchases.
Current role at each company
- KNSA Kiniksa Pharmaceuticals International, plcDirectoras of Jul 31, 2026
- CSTL Castle Biosciences IncDirectoras of Jun 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $509.8K
- 2 filings
- Net
- −$509.8K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Cole G Bradley as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KNSA Kiniksa Pharmaceuticals International, plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 (view filing)4:34 PM ET | Jul 29 | 2 days | Cole G BradleyDirector | SSaleClass A Ordinary Share | −3.67K | $81.43 | −$299.1K | −23.9%11.7K after |
CSTL Castle Biosciences Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Cole G BradleyDirector | SSale | −7.40K | $28.47 | −$210.7K | −27.7%19.3K after | 2 lots |